Cargando…

Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The burden of depressive disorder is large and new treatment approaches are required. Repurposing widely available drugs such as statins may be a time- and cost-effective solution. Statins have anti-inflammatory and anti-oxidant properties which have been shown to be relevant to the path...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Giorgi, Riccardo, De Crescenzo, Franco, Rizzo Pesci, Nicola, Martens, Marieke, Howard, Wendy, Cowen, Philip J., Harmer, Catherine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009386/ https://www.ncbi.nlm.nih.gov/pubmed/33784356 http://dx.doi.org/10.1371/journal.pone.0249409

Ejemplares similares

Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
por: De Giorgi, Riccardo, et al.
Publicado: (2021)

The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
por: De Giorgi, Riccardo, et al.
Publicado: (2023)

The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study
por: De Giorgi, Riccardo, et al.
Publicado: (2021)

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
por: De Giorgi, Riccardo, et al.
Publicado: (2023)

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder
por: Martens, Marieke A. G., et al.
Publicado: (2021)

Prevalence of Non-Affective Psychoses in Individuals with Autism Spectrum Disorders: A Systematic Review
por: De Giorgi, Riccardo, et al.
Publicado: (2019)

Neural representation of reward in recovered depressed patients
por: McCabe, Ciara, et al.
Publicado: (2009)

An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers
por: De Giorgi, Riccardo, et al.
Publicado: (2022)

An online experimental medicine trial on the effect of 28-day simvastatin administration on emotional processing, reward learning, working memory and salivary cortisol in healthy volunteers at risk for depression: OxSTEP protocol
por: Waters, Shona, et al.
Publicado: (2023)

An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers
por: Martens, Marieke Annie Gerdine, et al.
Publicado: (2021)

A Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Young People at Increased Familial Risk of Depression
por: Mannie, Zola N., et al.
Publicado: (2010)

Déjà-vu? Neural and behavioural effects of the 5-HT(4) receptor agonist, prucalopride, in a hippocampal-dependent memory task
por: de Cates, Angharad N., et al.
Publicado: (2021)

Using Attentional Bias Modification as a Cognitive Vaccine Against Depression
por: Browning, Michael, et al.
Publicado: (2012)

Meta-analysis of emotion recognition deficits in major depressive disorder
por: Dalili, M. N., et al.
Publicado: (2015)

Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
por: Capitão, Liliana P., et al.
Publicado: (2023)

Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex
por: Godlewska, Beata R, et al.
Publicado: (2018)

Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)

Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study
por: Mocking, Roel J T, et al.
Publicado: (2016)

Corrigendum: Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)

Statin for mood and inflammation among adult patients with major depressive disorder: an updated meta-analysis
por: Xiao, Xue, et al.
Publicado: (2023)

Neurochemistry of major depression: a study using magnetic resonance spectroscopy
por: Godlewska, Beata R., et al.
Publicado: (2014)

Epigenetic prediction of major depressive disorder
por: Barbu, Miruna C., et al.
Publicado: (2020)

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
por: Colwell, Michael J., et al.
Publicado: (2022)

Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability
por: Gillespie, Amy L., et al.
Publicado: (2022)

A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents
por: Capitão, Liliana P., et al.
Publicado: (2019)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression
por: Capitão, Liliana P, et al.
Publicado: (2020)

The Effect of the 5-HT(4) Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain
por: de Cates, Angharad N., et al.
Publicado: (2022)

Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes
por: Bridgeman, Stephanie, et al.
Publicado: (2019)

No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing
por: Cole, John J., et al.
Publicado: (2021)

The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers
por: McCabe, Ciara, et al.
Publicado: (2011)

Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
por: McCabe, Ciara, et al.
Publicado: (2010)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients
por: Godlewska, B. R., et al.
Publicado: (2012)

The neuroscience of depressive disorders: A brief review of the past and some considerations about the future
por: Kaltenboeck, Alexander, et al.
Publicado: (2018)

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
por: Schmaal, L, et al.
Publicado: (2016)

Effect of lithium administration on brain activity under an emotion regulation paradigm in healthy participants: a functional magnetic resonance imaging study
por: Artiach Hortelano, Pilar, et al.
Publicado: (2023)

The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
por: Godlewska, B R, et al.
Publicado: (2016)

Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers
por: Kaltenboeck, Alexander, et al.
Publicado: (2022)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n2p2iapokbrotfe25ut5jp8rc8